Philogen S.p.A. (PHIL.MI)

EUR 20.7

(-0.48%)

Net Income Summary of Philogen S.p.A.

Philogen S.p.A.'s latest annual net income in 2023 was -6.16 Million EUR , down -14.6% from previous year.
Philogen S.p.A.'s latest quarterly net income in 2023 FY was -6.16 Million EUR , down -14.6% from previous quarter.
Philogen S.p.A. reported an annual net income of -5.37 Million EUR in 2022, up 65.81% from previous year.
Philogen S.p.A. reported an annual net income of -15.72 Million EUR in 2021, down -18.37% from previous year.
Philogen S.p.A. reported a quarterly net income of -6.91 Million EUR for 2023 Q3, down -280.31% from previous quarter.
Philogen S.p.A. reported a quarterly net income of 3.83 Million EUR for 2023 Q1, up 204.3% from previous quarter.

Annual Net Income Chart of Philogen S.p.A. (2023 - 2017)

Historical Annual Net Income of Philogen S.p.A. (2023 - 2017)

Year	Net Income	Net Income Growth
2023	-6.16 Million EUR	-14.6%
2022	-5.37 Million EUR	65.81%
2021	-15.72 Million EUR	-18.37%
2020	-13.28 Million EUR	-1047.57%
2019	1.4 Million EUR	-62.14%
2018	3.7 Million EUR	48.12%
2017	2.5 Million EUR	0.0%

Year	Net Income	Net Income Growth
2023 Q2	3.83 Million EUR	0.0%
2023 Q3	-6.91 Million EUR	-280.31%
2023 Q1	3.83 Million EUR	204.3%
2023 FY	-6.16 Million EUR	-14.6%
2023 Q4	-6.91 Million EUR	0.0%
2022 Q4	-3.67 Million EUR	0.0%
2022 FY	-5.37 Million EUR	65.81%
2022 Q3	-3.67 Million EUR	-285.76%
2022 Q2	1.98 Million EUR	100.0%
2022 Q1	990 Thousand EUR	114.0%
2021 Q1	-4.32 Million EUR	-185.39%
2021 FY	-15.72 Million EUR	-18.37%
2021 Q4	-7.07 Million EUR	-100.0%
2021 Q3	-3.53 Million EUR	59.14%
2021 Q2	-8.65 Million EUR	-100.0%
2020 Q1	-4.21 Million EUR	-544.3%
2020 FY	-13.28 Million EUR	-1047.57%
2020 Q4	-1.51 Million EUR	0.0%
2020 Q2	-4.21 Million EUR	0.0%
2019 Q4	948 Thousand EUR	0.0%
2019 FY	1.4 Million EUR	-62.14%
2018 FY	3.7 Million EUR	48.12%
2017 FY	2.5 Million EUR	0.0%

Peer Net Income Comparison of Philogen S.p.A.

Name	Net Income	Net Income Difference
ARTERRA BIOSCIENCE	1.07 Million EUR	672.503%
Ulisse Biomed S.p.A.	-4.79 Million EUR	-28.439%